Genomic and Proteomic Analysis of Allogeneic Hematopoietic Cell Transplant Outcome. Seeking Greater Understanding the Pathogenesis of GVHD and Mortality
Open Access
- 1 January 2009
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 15 (1) , e1-e7
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- A biomarker panel for acute graft-versus-host diseaseBlood, 2009
- Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survivalBlood, 2008
- Plasma Elevations of Tumor Necrosis Factor-Receptor-1 at Day 7 Postallogeneic Transplant Correlate with Graft-versus-Host Disease Severity and Overall Survival in Pediatric PatientsTransplantation and Cellular Therapy, 2008
- CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host diseaseBlood, 2008
- Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology GroupBlood, 2008
- Interleukin‐1 alpha genotype and outcome of unrelated donor haematopoietic stem cell transplantation for chronic myeloid leukaemiaBritish Journal of Haematology, 2007
- Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patientsTransplant Immunology, 2006
- Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantationBlood, 2005
- IL-6 and IL-10 Promoter Gene Polymorphisms of Patients and Donors of Allogeneic Sibling Hematopoietic Stem Cell Transplants Associate With the Risk of Acute Graft-Versus-Host DiseaseHuman Immunology, 2005
- Initial sequencing and analysis of the human genomeNature, 2001